Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Individualized Therapeutics Could Get Boost From NIH Platform Gene Therapy Pilot

Apr 03 2020

• By Sue Sutter

Stand out from the crowd — Engineering gene therapies for individual patients poses regulatory and manufacturing challenges. • Source: Shutterstock

Related Content

Individualized Gene Therapy: US FDA Considering Device-Like Manufacturing Approval Process

Feb 28 2020

US FDA CBER Chief Calls For Industry-Academia Collaboration In Developing Treatments For Ultra-Rare Diseases

Jul 02 2019

Now It Really Is Personal: US FDA 'Rushing' To Develop Policy For 'Bespoke Therapies'

Jun 12 2019

One Patient, Many Questions: Milasen ‘N of 1’ Trial Provides Early Template For Individualized Genomic Medicine

Oct 11 2019

White Flag Raised: UniQure Gives Up On Glybera, But Not Gene Therapies

Apr 21 2017

Related Companies

uniQure N.V.

Additional Topics

United States Gene Therapy Regenerative Medicine Rare Diseases Regulation BioPharmaceutical

More from Cell & Gene Therapies

More from Advanced Technologies

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window